Invention Grant
- Patent Title: Crystalline forms of PARP inhibitors
-
Application No.: US15529883Application Date: 2015-11-25
-
Publication No.: US10150772B2Publication Date: 2018-12-11
- Inventor: Stephen J. Bierlmaier , Ralph C. Haltiwanger , Martin J. Jacobs
- Applicant: CEPHALON, INC.
- Applicant Address: US PA Frazer
- Assignee: CEPHALON, INC.
- Current Assignee: CEPHALON, INC.
- Current Assignee Address: US PA Frazer
- Agency: Foley & Lardner LLP
- Agent Gilberto M. Villacorta
- International Application: PCT/US2015/062572 WO 20151125
- International Announcement: WO2016/086080 WO 20160602
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07C59/06 ; C07C53/10 ; C07C59/245 ; C07D207/28 ; C07C57/15
Abstract:
The present disclosure relates to crystalline forms of 4,5,6,7-tetrahydro-11-methoxy-2-[(4-methyl-1-piperazinyl)methyl]-1H-cyclopenta[a]pyrrolo[3,4-c]carbazole-1,3(2H)-dione, including salts forms and free base forms.
Public/Granted literature
- US20170267683A1 CRYSTALLINE FORMS OF PARP INHIBITORS Public/Granted day:2017-09-21
Information query
